All articles

Parenthood_cancer
Clinical practice

Bringing a child into a family’s battle with cancer

Available data now allows evidence-based treatment of cancer diagnosed during pregnancy and new therapies are improving many young patients’ survival prospects, but couples’ preferences and values must continue to guide medical teams even when hope is scarce

Read more
Collaboration_doctors
Clinical practice

What do non-oncologists know about cancer care?

A survey reveals that physicians outside the field of oncology are insufficiently updated on the latest advances in cancer care, thus increasing the risk of providing misleading information and inadequate support to patients.

Read more
cancer_screening
Cancer prevention

Cancer screening programmes, a long road back to normal

In many countries, cancer screening activities are still suffering a complete shutdown, and according to public policy experts this may limit opportunities of a timely diagnosis especially to socio-economically vulnerable populations.
Read more
empowerment
Clinical practice

Is COVID-19 turning back the clock for patient empowerment?

After years of progress in empowering patients with cancer to play a more active role in their care, the COVID-19 pandemic is leaving many feeling anxious with little control over if, when or how they will receive a diagnosis or treatment. 
Read more
Sustainable cancer care

Translating commitments into action

The World Health Organization (WHO) defines a National Cancer Control Plan as ‘a public health programme designed to reduce cancer incidence and mortality and improve quality of life of cancer patients, through the systematic and equitable implementation of evidence-based strategies for prevention, early detection, diagnosis, treatment, and palliation, making the best use of available resources’.

Read more
Cancer prevention

What should oncologists know about e-cigarettes?

Electronic nicotine delivery systems (ENDS) are battery-powered products that create an aerosol by heating a liquid consisting of propylene glycol and vegetable glycerin and flavouring agents. The liquid may or may not (but usually does) contain nicotine, at variable doses. Differently from conventional cigarettes, there is no combustion of tobacco in ENDS, thus making people think they cause less harm. However, the varying voltage that is applied to the liquid creates a mixture of potentially toxic substances in the aerosols that are then inhaled by users.

Read more
Supportive care

Integrating the patient’s voice into clinical settings

While patient-reported outcomes (PROs) are now an integral part of many phase III trials, their incorporation into routine clinical practice is hampered by economic and time pressures among healthcare professionals. However, with the advent of electronic-based questionnaires, current boundaries are likely to be stretched.

Read more
Gender equality

Why we need to investigate sex differences in cancer research

An innovative approach

Sex- and gender-sensitive medicine postulates that differences in biological sex, gender identity, role and relations all impact health and disease, and may have implications for prevention, screening, diagnosis and treatment. Its goal is to learn from these differences to improve care and treatment for men and women.

Read more
Innovation

Beyond blood with liquid biopsies

Pioneering work by Joan Seoane and colleagues from Vall d’Hebron Institute of Oncology in Barcelona makes use of cerebrospinal fluid (CSF) to detect circulating tumour DNA (ctDNA)  in patients with brain tumours. Where blood and plasma analysis have failed, a new era for liquid biopsies based on different physiological fluids for different tumour types is on the horizon.

Read more
Specialised education

Nurture young oncologists in Asia

LGP in Asia

The first ESMO Leaders Generation Programme (LGP) Asia will be a four-day course held in Singapore from 18 to 21 November 2019. The course will provide participants with an overview of how ESMO works, offering workshops, discussions and hands-on media and leadership skills training. The programme is aimed at qualified medical or clinical oncologists, working in the Asia-Pacific region and who are ESMO members aged between 31 and 45.

Read more
Sustainable cancer care

The time to act is now

Shortages of inexpensive essential cancer medicines is a growing emergency in Europe, although the size of the problem is still uncertain as data are lacking. ESMO is at the forefront in order to drive concerted and collaborative action. A call to action was launched last April as the issue cannot be tackled by countries individually and establishing a strong European leadership is crucial.

Read more

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.